Trials / Completed
CompletedNCT02056743
Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers
Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers; Open-label, Parallel Group
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the possibility of drug interactions before and after taking red ginseng or fermented-red ginseng by estimating metabolic rate of indicator drugs for cytochrome P450 and P-glycoprotein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CYP cocktail | Each group administered CYP cocktail (Caffeine 200mg + Losartan 50mg + Omeprazole 20mg + Dextromethorphan 30mg + Midazolam 7.5mg) under fasting conditions. |
| DRUG | Fexofenadine 30mg | Each group administered Fexofenadine 30mg under fasting conditions. |
| DIETARY_SUPPLEMENT | Red ginseng | During 4\~17th days, end of the period 1, the group of red ginseng administered red ginseng extract. |
| DIETARY_SUPPLEMENT | Fermented-red ginseng | During 4\~17th days, end of the period 1, the group of fermented-red ginseng administered fermented-red ginseng extract. |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2013-10-01
- First posted
- 2014-02-06
- Last updated
- 2014-02-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02056743. Inclusion in this directory is not an endorsement.